These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11731761)

  • 1. French loan arranger seeks biotech posse.
    Hodgson J
    Nat Biotechnol; 2001 Dec; 19(12):1089. PubMed ID: 11731761
    [No Abstract]   [Full Text] [Related]  

  • 2. French research minister targets IT and biotech.
    McCabe H
    Nature; 2000 May; 405(6783):106. PubMed ID: 10821237
    [No Abstract]   [Full Text] [Related]  

  • 3. New law to boost French biotech industry.
    Louët S
    Nat Biotechnol; 1999 Nov; 17(11):1055. PubMed ID: 10545900
    [No Abstract]   [Full Text] [Related]  

  • 4. Ambitious French biotech plan faces EU hurdle.
    Hodgson J
    Nat Biotechnol; 2003 Feb; 21(2):113-4. PubMed ID: 12560821
    [No Abstract]   [Full Text] [Related]  

  • 5. Transferring EU-funded biotechnology research to European bioindustry.
    Lawler C; van der Meer R; Viseur J
    Nat Biotechnol; 1998 Jun; 16(6):494. PubMed ID: 9624665
    [No Abstract]   [Full Text] [Related]  

  • 6. Possibilities for funding of applied biotechnology research in the sixth Framework Programme.
    Lucas J
    Commun Agric Appl Biol Sci; 2003; 68(2 Pt A):3-12. PubMed ID: 15296131
    [No Abstract]   [Full Text] [Related]  

  • 7. French refuse to implement biotech patent directive.
    Louët S
    Nat Biotechnol; 2000 Aug; 18(8):820. PubMed ID: 10932143
    [No Abstract]   [Full Text] [Related]  

  • 8. Biotechnology. French drug industry initiative.
    Anderson C
    Nature; 1991 Oct; 353(6344):487. PubMed ID: 1922346
    [No Abstract]   [Full Text] [Related]  

  • 9. Biotechnology and sustainability: the role of transatlantic cooperation in research and innovation.
    Aguilar A; Bochereau L; Matthiessen-Guyader L
    Trends Biotechnol; 2008 Apr; 26(4):163-5. PubMed ID: 18295918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vacuum at the heart of Europe.
    Nature; 1999 Nov; 402(6757):1. PubMed ID: 10573400
    [No Abstract]   [Full Text] [Related]  

  • 11. EU plant programs wither under Framework V.
    Heselmans M
    Nat Biotechnol; 1999 Nov; 17(11):1056. PubMed ID: 10545901
    [No Abstract]   [Full Text] [Related]  

  • 12. BIO 2006 Annual International Convention. The expanding biotech industry of France.
    Zarkowska T
    IDrugs; 2006 Jun; 9(6):383-5. PubMed ID: 16752302
    [No Abstract]   [Full Text] [Related]  

  • 13. European biotechnology turns East.
    Sansom C
    Nat Biotechnol; 1999 May; 17(5):437-9. PubMed ID: 10331797
    [No Abstract]   [Full Text] [Related]  

  • 14. French geneticists raise worries over use of new genome funds.
    Butler D
    Nature; 1999 May; 399(6733):185-6. PubMed ID: 10353229
    [No Abstract]   [Full Text] [Related]  

  • 15. UK seeks to relax shareholder preemption rights.
    Vermij P
    Nat Biotechnol; 2005 Jan; 23(1):7. PubMed ID: 15637600
    [No Abstract]   [Full Text] [Related]  

  • 16. France boosts funding for biotechnology start-ups.
    Goodman S
    Nature; 2001 Dec; 414(6864):573. PubMed ID: 11740520
    [No Abstract]   [Full Text] [Related]  

  • 17. To patent or not to patent: the European Union's new biotech directive.
    Nenow L
    Houst J Int Law; 2001; 23(3):569-607. PubMed ID: 12769115
    [No Abstract]   [Full Text] [Related]  

  • 18. BioPolis report paints fractured picture of EU biotech.
    Moran N
    Nat Biotechnol; 2007 Sep; 25(9):956-7. PubMed ID: 17846612
    [No Abstract]   [Full Text] [Related]  

  • 19. German regions compete for biotech funds.
    Abbott A; Schiermeir Q
    Nature; 1996 Feb; 379(6568):759. PubMed ID: 8587590
    [No Abstract]   [Full Text] [Related]  

  • 20. Funding crisis for Indian biotech centre.
    Jayaraman KS
    Nature; 2000 Feb; 403(6771):694. PubMed ID: 10733382
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.